Breast cancer is the most frequently diagnosed cancer in women. Most breast cancer are hormone receptor-positive (estrogen and/or progesterone receptor-positive) and need hormones to grow. After surgery, those cancers can be treated by various hormone therapy which include modulators and degraders of estrogen receptors, and blockers of estrogen production. Although with generally favorable outcome, certain percentage of those cancers develop resistance to hormone therapy, which rises the risk of breast cancer recurrence, breast cancer in the opposite breast, and death from breast cancer. For those cases it is important to understand mechanisms that caused resistance, to identify biomarkers which could predict the resistance development, and finally, to discover more efficient combined therapy or improved follow-up protocol.

Istraživačko-razvojni projekt čija sredstva su osigurana u sklopu poziva 'Jačanje kapaciteta za istraživanje, razvoj i inovacije' (IRI) iz Europskoga fonda za regionalni razvoj. 

Istraživačko-razvojni projekt čija sredstva su osigurana u sklopu poziva 'Jačanje kapaciteta za istraživanje, razvoj i inovacije' (IRI) iz Europskoga fonda za regionalni razvoj. 

Otkriće akvaporina (AQP), membranskih pora koje kanaliziraju ulaz vode u stanicu, promijenilo je percepciju o pasivnom ulasku raznih molekula u stanicu.